Related Experiment Videos
Pharmacological interferences with the renin-angiotensin system
Arzneimittel-Forschung
|January 1, 1984
Summary
The renin-angiotensin system (RAS) plays a key role in hypertension. Inhibiting the RAS offers potential antihypertensive treatments by targeting angiotensin II (ANG II) formation or action.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- The renin-angiotensin system (RAS) is crucial for maintaining blood pressure.
- Dysregulation of the RAS contributes to various forms of hypertension.
Purpose of the Study:
- To explore pharmacologic interventions targeting the RAS for antihypertensive therapy.
- To review different strategies for inhibiting angiotensin II (ANG II) activity.
Main Methods:
- Review of existing literature on RAS inhibition.
- Categorization of interventions based on their site of action within the RAS pathway.
Main Results:
- Multiple points for pharmacologic interference exist within the RAS.
- Inhibitors of the converting enzyme are clinically used for hypertension.
- ANG II receptor blockers offer another therapeutic avenue.
Conclusions:
- Targeting the RAS is a validated strategy for developing antihypertensive agents.
- Various experimental and clinical approaches exist to inhibit the RAS.
- Converting enzyme inhibitors are established treatments, while other methods show promise.